Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Leggett & Platt
(NY:
LEG
)
12.23
+0.10 (+0.82%)
Streaming Delayed Price
Updated: 10:13 AM EDT, Oct 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Leggett & Platt
< Previous
1
2
3
4
5
6
7
Next >
My Top Dividend King to Buy and Hold for the Next 10 Years, and It Isn't Even Close
August 14, 2023
This stock offers a high dividend yield, impressive dividend growth, and a lot more.
Via
The Motley Fool
Dividend Income Update July 2023
August 07, 2023
The start of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated.
Via
Talk Markets
Tempur Sealy To Face Earnings Risk From Cybersecurity Breach, Macroeconomic Trends, Says Analyst
August 01, 2023
Wedbush analyst Seth Basham reiterated an Outperform rating on the shares of Tempur Sealy International Inc (NYSE: TPX) with a price target of $55.
Via
Benzinga
3 Dividend Stocks You Better Be Buying on Each and Every Dip
July 27, 2023
Buying great companies when their stocks are beaten down is an excellent path to generating outsized portfolio returns.
Via
InvestorPlace
2 Red-Hot Dividend Kings and 1 Unstoppable High-Yield Dividend Stock to Power Your Passive Income
July 27, 2023
These growing businesses can support future dividend raises.
Via
The Motley Fool
A Look Into Leggett & Platt's Debt
June 20, 2023
Via
Benzinga
Earnings Preview: Leggett & Platt
April 28, 2023
Via
Benzinga
Goldman Sachs Downgrades Leggett & Platt: Here's What You Need To Know
April 11, 2023
Via
Benzinga
Leggett & Platt's Earnings Outlook
February 03, 2023
Via
Benzinga
Earnings Scheduled For July 31, 2023
July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million.
Via
Benzinga
Leggett & Platt's Earnings: A Preview
July 28, 2023
Via
Benzinga
Recent Stock Purchases For June/July 2023
July 23, 2023
With July ending soon and the markets on an uptrend, I decided to add to some of my lagging existing positions. I couldn’t resist some juicy yields as a result of stock price declines, and I decided to...
Via
Talk Markets
Leggett & Platt Announces 2Q 2023 Earnings Call
July 17, 2023
From
Leggett & Platt, Incorporated
Via
GlobeNewswire
July 2023 Stock Considerations
July 08, 2023
With a new trading month already in full swing it is time, once again, to highlight some of my potential stock purchases.
Via
Talk Markets
Here's Why I Bought This Struggling Stock
June 02, 2023
I was looking for an industrial stock to replace 3M in my portfolio and decided that Leggett & Platt would fit the bill.
Via
The Motley Fool
Better Buy: 3M vs. Leggett & Platt
May 20, 2023
If you are looking for a high-yield industrial Dividend King, Leggett & Platt comes with less baggage than better-known 3M.
Via
The Motley Fool
Don’t Guess, Know When To Buy Or Sell A Stock - Part II
May 12, 2023
A review and analysis of the stock market.
Via
Talk Markets
Dividend Income Update April 2023
May 11, 2023
With May already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income their portfolios generated.
Via
Talk Markets
Check Out 3 Consumer Stocks With Over 5% Dividend Yields From Wall Street's Most Accurate Analysts
May 03, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Leggett & Platt Announces 1Q 2023 Earnings Call
April 18, 2023
From
Leggett & Platt, Incorporated
Via
GlobeNewswire
Earnings Scheduled For May 1, 2023
May 01, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2023
April 11, 2023
Via
Benzinga
Tuesday Talk: April Flowers
April 04, 2023
So far it's April flowers as stocks continued upwards on Monday, with the announced OPEC+ production cut creating a rally in Oil related issues.
Via
Talk Markets
April 2023 Stock Considerations
April 04, 2023
Let’s take a look at my April stock considerations which are similar to recent considerations from one to four months ago.
Via
Talk Markets
Recent Stock Purchases For March 2023
March 25, 2023
As readers may know by now, I make stock purchases every single month, no matter what is going on in the world. This month, I went heavier than I normally do, deploying over $3,000. Let's take a look.
Via
Talk Markets
Could Tempur Sealy be the Sleeper Stock of 2023?
February 14, 2023
Bedding products manufacturer Tempur Sealy International Inc. (NYSE: TPX) stock has been quietly rising towards all-time highs. The world's largest bedding
Via
MarketBeat
Dividend Income Update For January 2023
February 12, 2023
Without rehashing the wild ride we experienced in the market over the last few months, I could find comfort in one thing: my dividends (even if dividend cuts are on the table these days). Let's see how...
Via
Talk Markets
Why Bed Bath & Beyond Fell Almost 30%; Here Are 20 Stocks Moving Premarket
February 07, 2023
Gainers
Via
Benzinga
Earnings Scheduled For February 6, 2023
February 06, 2023
Companies Reporting Before The Bell • Cummins (NYSE:CMI) is projected to report quarterly earnings at $4.56 per share on revenue of $7.21 billion.
Via
Benzinga
Leggett & Platt Announces 4Q 2022 Earnings Call
January 24, 2023
From
Leggett & Platt, Incorporated
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.